Methinks Software, S.L
SpainFDA applicant, unverified
- Devices
- 2
What Methinks Software, S.L makes
Methinks Software, S.L. develops software-based medical devices for stroke assessment, including the Methinks CTA Stroke and Methinks NCCT Stroke. These tools analyze computed tomography angiography (CTA) and non-contrast computed tomography (NCCT) scans to support early stroke diagnosis and treatment planning.
The company’s portfolio consists of Class II devices, regulated under the FDA’s 510(k) clearance process. These products are listed in the FDA’s 510(k) database. The manufacturer is based in the United States.
Catalogue
Methinks CTA Stroke Ref K251590
Regimes: 510(k) Registry: 510(k)Methinks NCCT Stroke Ref K250685
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Methinks Software, S.L have in the registry?
The registry currently lists 2 devices for Methinks Software, S.L. Devices recorded under merged duplicate company entries are counted once.
Which registries list Methinks Software, S.L's devices?
Among its 2 most recently registered devices, Methinks Software, S.L has devices listed in FDA 510(k) (2 devices).
What risk classes do Methinks Software, S.L's devices fall under?
Among its 2 most recently registered devices, the classes recorded for Methinks Software, S.L's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Methinks Software, S.L in the registry?
The most recently registered devices listed for Methinks Software, S.L include Methinks CTA Stroke and Methinks NCCT Stroke.